For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
New legislation seeks to shuffle the deck chairs on the sinking No Surprises Act
On October 8, Rep. Frank Pallone (D-NJ) introduced the Lower Premiums, Faster Payments Act as a fix for the disastrous No Surprises Act (NSA).
Blog
This week in health care policy: September 28 – October 2, 2026
Drug pricing CMS finalizes GLOBE pilot. On September 30, CMS finalized the Global Benchmark for Efficient Drug Pricing model, a…
Blog
This week in health care policy: September 21–25, 2026
Innovation watch FDA approves the first treatment for Sanfilippo syndrome. On September 17, the FDA approved Ultragenyx’s Fayuvi, a one-time…
Search Posts
Newsletter
CEI Daily Update
Issues in the News 1. ENVIRONMENT Danish scientist Bjørn Lomborg garners high-profile media attention for his new book, “Cool It:…
Blog
Vioxx Class Action Rejected in New Jersey
The New Jersey Supreme Court just rejected a nationwide class action against Merck over its drug Vioxx, recognizing that it would be inappropriate to…
Newsletter
Issues in the News<?xml:namespace prefix = o ns = “urn:schemas-microsoft-com:office:office” /> 1. HEALTH AND SAFETY A recent…
Newsletter
CEI Daily Update
Issues in the News 1. ENVIRONMENT Consumers in the UK question the value of the billions of pounds paid every year in…
Blog
Alarming Waste
Today’s Washington Post includes a story on bisphenol A, a chemical that has been used to make flexible, clear plastic products–including baby bottles–since the…
Blog
FDA Tobacco Regulation Bill: A Trojan Horse?
PR Watch has an interesting story on the cynical baptist-bootlegger alliance behind the bill to give the FDA oversight over the tobacco industry, which…